New research suggests beta-blockers might help protect the brain after traumatic brain injury by reducing neuronal damage biomarkers.
Explore how predictive biomarkers are transforming the diagnosis and treatment of traumatic brain injury, improving patient outcomes through personalized medicine.
Discover how GFAP and UCH-L1 proteins are transforming forensic investigation of traumatic brain injuries through cutting-edge biomarker analysis.